Experimental assessment of counterfog bioaerosol fast sampler for virus detection and decontamination

Abstract The respiratory system is equipped with several defence mechanisms to protect the body from microorganisms and airborne pathogens. There are situations where the respiratory system can be overwhelmed or compromised and infection happens, especially in individuals with weakened immune systems. Airborne pathogens are a serious risk for human and animal health, as exemplified by the challenges faced during the COVID-19 pandemic. The list includes viruses of varying severity such as Influenza virus, SARS-CoV-2, measles virus, Varicella-Zoster Virus, or Respiratory syncytial virus among others. Smaller particles can remain suspended in the air for longer periods and may reach the lower respiratory tract, including the alveoli in the lungs. The real-time detection of these pathogens in the air presents a significant challenge. The aerosols, especially those carrying viruses, are so small that they often elude conventional air samplers, making it difficult both to detect their presence and to remove them effectively from the air. This work introduces a recent technique designed for rapid aerosol sampling, with a particular emphasis on virus sampling. The system underwent calibration using artificial ɸ29 virus aerosols and was subsequently tested with naturally emitted aerosols of SARS-CoV-2. A series of tests were conducted in diverse settings, including hospitals, farms, offices, and railway cars. The equipment is also capable of swiftly removing bioaerosols from the air, thereby facilitating effective decontamination. The relevance of this technology lies in its capability for swift detection and elimination of viruses and other kinds of aerosols from air, facilitating prompt decision-making during high-risk events.